ARCHIVES

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Cyclamate Review Committee Starts Survey; Inventor Castigates NCI

September 12, 1975

In Brief: Caplan Receives NSB Public Service Award

March 28, 2014

BMI May Be Prognostic Tool For Types Of Breast Cancer

March 28, 2008

Funding opportunities listed.

January 16, 2004

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

Radiation To Stem Cell Niche Improved PFS In Glioblastoma

August 27, 2010